1. Home
  2. MASI vs BIO Comparison

MASI vs BIO Comparison

Compare MASI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASI
  • BIO
  • Stock Information
  • Founded
  • MASI 1989
  • BIO 1952
  • Country
  • MASI United States
  • BIO United States
  • Employees
  • MASI N/A
  • BIO N/A
  • Industry
  • MASI Medical/Dental Instruments
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • MASI Health Care
  • BIO Industrials
  • Exchange
  • MASI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • MASI 8.1B
  • BIO 7.7B
  • IPO Year
  • MASI 2007
  • BIO N/A
  • Fundamental
  • Price
  • MASI $141.97
  • BIO $292.21
  • Analyst Decision
  • MASI Buy
  • BIO Strong Buy
  • Analyst Count
  • MASI 6
  • BIO 4
  • Target Price
  • MASI $189.00
  • BIO $333.50
  • AVG Volume (30 Days)
  • MASI 864.3K
  • BIO 310.9K
  • Earning Date
  • MASI 08-05-2025
  • BIO 07-31-2025
  • Dividend Yield
  • MASI N/A
  • BIO N/A
  • EPS Growth
  • MASI N/A
  • BIO N/A
  • EPS
  • MASI N/A
  • BIO 11.49
  • Revenue
  • MASI $2,153,800,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • MASI N/A
  • BIO N/A
  • Revenue Next Year
  • MASI $7.74
  • BIO $3.42
  • P/E Ratio
  • MASI N/A
  • BIO $25.81
  • Revenue Growth
  • MASI 25.86
  • BIO N/A
  • 52 Week Low
  • MASI $107.98
  • BIO $211.43
  • 52 Week High
  • MASI $194.88
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • MASI 38.86
  • BIO 60.95
  • Support Level
  • MASI $143.11
  • BIO $283.96
  • Resistance Level
  • MASI $149.59
  • BIO $308.44
  • Average True Range (ATR)
  • MASI 4.12
  • BIO 7.62
  • MACD
  • MASI -0.46
  • BIO 0.73
  • Stochastic Oscillator
  • MASI 2.63
  • BIO 64.50

About MASI Masimo Corporation

Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: